David Uttley Returns to Kilimanjaro

David Uttley Returns to Kilimanjaro

"In August 2023, I stood atop Mount Kilimanjaro, carrying a deeply personal weight - my mother's ashes, honouring her life and spirit at one of the most powerful places on

CHMP RECOMMENDS APPROVAL OF OPDIVO (NIVOLUMAB)

Bristol Myers Squibb (NYSE: BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo (nivolumab) as

DAVID UTTLEY & KILIMANJARO

David has already done some fundraising for Melanoma UK and decided a few weeks ago that he would climb Kilimanjaro. Not the type to let the grass grow, David's fundraising
JEWSON LIVE 2022 #HARDHATYOURSKIN

JEWSON LIVE 2022 #HARDHATYOURSKIN

After a two-year break, visitors to the event will be treated to a jam-packed day, full of exclusive offers, speakers, competitions, product demonstrations, giveaways and Melanoma UK will be on

IMMUNOTHERAPY BREAKTHROUGH

When CRUK, Prof. Gareth Thomas and a team of researchers announced after a six year study they were making a breakthrough in the treatment of cancers through immunotherapy, our amazing

Watch our B-RAF Animated Video

Melanoma is the most serious form of skin cancer and the fifth most common cancer in the UK, with over 40 cases diagnosed every day.